Improved Metabolic Function By encouraging your bodys own GLP-1 production, these alternatives support better insulin sensitivity , glucose tolerance , and overall metabolic efficiency
However, its unfortunate that demand for GLP-1s has led to a shortage of critical medication for patients with insurance coverage that are managing chronic issues
The medication is typically administered via injection and works by enhancing insulin secretion, reducing appetite, and slowing gastric emptying
In December 2025, the Food and Drug Administration (FDA) approved an oral pill form of Wegovy for weight loss, and in April 2026 approved the once-daily oral GLP-1 drug Foundayo (orforglipron) also for weight loss
Take Control of Your Health Journey Today
Ephedra and bitter orange: cardiovascular risk Both ephedra (banned by the FDA) and bitter orange (its legal cousin) carry cardiovascular risks including elevated heart rate, blood pressure spikes, and in extreme cases, heart attacks and strokes